Superior efficacy with a fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with insulin degludec and liraglutide in insulin‐naïve Japanese patients with type 2 diabetes in a phase 3, open‐label, randomized trial

AIMS: To investigate the efficacy and safety of insulin degludec/liraglutide (IDegLira) compared with its individual components in Japanese people with type 2 diabetes (T2D) uncontrolled on an oral antidiabetic drug (OAD). MATERIALS AND METHODS: This 52‐week, open‐label, multicentre, treat‐to‐target...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes Obes Metab
Autors principals: Kaku, Kohei, Araki, Eiichi, Tanizawa, Yukio, Ross Agner, Bue, Nishida, Tomoyuki, Ranthe, Mattis, Inagaki, Nobuya
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Publishing Ltd 2019
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6899795/
https://ncbi.nlm.nih.gov/pubmed/31407845
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13856
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars